Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.9500
+0.0500 (5.56%)
At close: Oct 15, 2026
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $6.79 million as of October 15, 2026. It is the 43,569th most valuable company in the world and the 5,844th biggest in the United States. Its market cap has decreased by 14.17% in one year.
Market Cap
6.79M
Enterprise Value
10.71M
Revenue
n/a
Global Rank
Country Rank
#5,844 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.35M to 6.79M, a decrease of -69.60%. That is a compound annual growth rate of -6.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 6.79M | 17.28% |
| Dec 31, 2025 | 5.79M | -50.77% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncotelic Therapeutics | 9.15M |
| Hepion Pharmaceuticals | 8.95M |
| Adaptimmune Therapeutics | 7.95M |
| Zeo ScientifiX | 7.05M |
| OSR Health | 7.03M |
| TRON Group | 6.99M |
| VitaSpring Biomedical | 6.58M |
| Reviva Pharmaceuticals Holdings | 6.27M |